Kailera Therapeutics

Business Health Technology

Kailera Therapeutics $625M IPO

Obesity-focused biotech Kailera Therapeutics jumps 60% in a massive $625 million IPO debut.

Weight loss drug developer Kailera climbs 50% on trading debut Seeking Alpha — Apr 17, 17:58 PM
Obesity Firm Kailera Therapeutics Up 63% After $625 Million IPO Bloomberg — Apr 17, 17:41 PM
Kailera upsizes IPO to raise $625 million Boston Globe — Apr 17, 14:56 PM
GLP-1 developer Kailera prices IPO at $16 per share to raise $625M Seeking Alpha — Apr 17, 14:03 PM